Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Fuji
Federal Trade Commission
Dow
Chubb
AstraZeneca
Boehringer Ingelheim
Merck

Generated: November 15, 2018

DrugPatentWatch Database Preview

Suppliers and packages for tradename: ADDERALL XR 10

« Back to Dashboard

ADDERALL XR 10

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Shire ADDERALL XR 10 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303 NDA AUTHORIZED GENERIC Global Pharmaceuticals, Division of Impax Laboratories Inc. 0115-1328-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1328-01)
Shire ADDERALL XR 10 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303 NDA AUTHORIZED GENERIC Global Pharmaceuticals, Division of Impax Laboratories Inc. 0115-1329-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1329-01)
Shire ADDERALL XR 10 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303 NDA AUTHORIZED GENERIC Global Pharmaceuticals, Division of Impax Laboratories Inc. 0115-1330-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1330-01)
Shire ADDERALL XR 10 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303 NDA AUTHORIZED GENERIC Global Pharmaceuticals, Division of Impax Laboratories Inc. 0115-1331-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1331-01)
Shire ADDERALL XR 10 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303 NDA AUTHORIZED GENERIC Global Pharmaceuticals, Division of Impax Laboratories Inc. 0115-1332-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1332-01)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Citi
McKesson
Fuji
Mallinckrodt
Medtronic
Cantor Fitzgerald
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.